These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8749270)

  • 1. Practical issues for the use of ACE inhibitors in acute myocardial infarction.
    Testa M; Sonnenblick EH; Lejemtel TH
    J Cardiovasc Risk; 1995 Oct; 2(5):429-33. PubMed ID: 8749270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of congestive heart failure by ACE inhibition in patients with acute myocardial infarction.
    Sigurdsson A; Swedberg K
    J Cardiovasc Risk; 1995 Oct; 2(5):406-12. PubMed ID: 8749267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
    Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R
    Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
    Young JB
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A; Swedberg K
    Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical benefit of angiotensin converting enzyme inhibition after acute myocardial infarction: myocardial reperfusion revisited.
    Renkin J
    J Hypertens Suppl; 1996 Dec; 14(6):S15-9. PubMed ID: 9023710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug differences between ACE inhibitors in experimental settings and clinical practice.
    Voors AA; Kingma JH; van Gilst WH
    J Cardiovasc Risk; 1995 Oct; 2(5):413-22. PubMed ID: 8749268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of angiotensin-converting enzyme inhibitors in the treatment and prevention of congestive heart failure.
    Toher CA; Francis GS
    Coron Artery Dis; 1993 Jan; 4(1):37-43. PubMed ID: 8269182
    [No Abstract]   [Full Text] [Related]  

  • 11. How to use ACE-inhibitors, beta-blockers, and newer therapies in AMI.
    Maggioni AP; Latini R
    Am Heart J; 1999 Aug; 138(2 Pt 2):S183-7. PubMed ID: 10426880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function.
    Reikvam A; Kvan E; Landmark K; Aursnes I;
    Scand Cardiovasc J; 2003 Jun; 37(3):130-4. PubMed ID: 12881153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for immediate angiotensin-converting enzyme inhibition in patients with acute myocardial infarction.
    LeJemtel TH; Hochman JS; Sonnenblick EH
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):47S-51S. PubMed ID: 7775715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond.
    Lombardi WL; Litwin SE
    Coron Artery Dis; 1999 Sep; 10(6):361-8. PubMed ID: 10474785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of ACE inhibitors in heart failure (mechanism of action)].
    Drexler H
    Z Kardiol; 1992; 81 Suppl 4():85-91. PubMed ID: 1290308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants.
    Michaels AD; Maynard C; Every NR; Barron HV
    Am J Cardiol; 1999 Nov; 84(10):1176-81. PubMed ID: 10569326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.